Hepanova
Gaithersburg, US
Biotech
Founders & leadership
QL
QISHENG LIExecutive Officer, Director
KL
KE LIDirector
YW
Yuanzhang WangExecutive Officer, Director
BX
Belle X WangExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$450KraisedJan 2021 · 1 investors · Pharmaceuticals
Rule 506(b)$1MraisedOct 2019 · 1 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.